United Therapeutics Corp. (UTHR) PT Raised to 'Street High' $275 at Oppenheimer Following OPCO Physician Survey Results
Tweet Send to a Friend
Oppenheimer analyst Hartaj Singh raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to a 'Street High' $275.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
